|
1.
|
Al-Hajj M and Clarke MF: Self-renewal and
solid tumor stem cells. Oncogene. 23:7274–7282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar
|
|
3.
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
6.
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
9.
|
Schwartz GJ, Mehta RH, Wenig BL, Shaligram
C and Portugal LG: Salvage treatment for recurrent squamous cell
carcinoma of the oral cavity. Head Neck. 22:34–41. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Lindahl R: Aldehyde dehydrogenases and
their role in carcinogenesis. Cri Rev Biochem Mol Biol. 27:283–335.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS and Dontu G: ALDH1
is a marker of normal and malignant human mammary stem cells and a
predictor of poor clinical outcome. Cell Stem Cell. 1:555–567.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Ibarra I, Erlich Y, Muthuswamy SK,
Sachidanandam R and Hannon GJ: A role for microRNAs in maintenance
of mouse mammary epithelial progenitor cells. Genes Dev.
21:3238–3243. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Jiang F, Qiu Q, Khanna A, Todd NW, Deepak
J, Xing L, Wang H, Liu Z, Su Y, Stass SA and Katz RL: Aldehyde
dehydrogenase 1 is a tumor stem cell-associated marker in lung
cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Balicki D: Moving forward in human mammary
stem cell biology and breast cancer prognostication using ALDH1.
Cell Stem Cell. 1:485–487. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Feldmann G, Dhara S, Fendrich V, Bedja D,
Beaty R, Mullendore M, Karikari C, Alvarez H, Iacobuzio-Donahue C,
Jimeno A, Gabrielson KL, Matsui W and Maitra A: Blockade of
hedgehog signaling inhibits pancreatic cancer invasion and
metastases: a new paradigm for combination therapy in solid
cancers. Cancer Res. 67:2187–2196. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Moreb JS: Aldehyde dehydrogenase as a
marker for stem cells. Curr Stem Cell Res Ther. 3:237–246. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Rahadiani N, Ikeda J, Mamat S, Matsuzaki
S, Ueda Y, Umehara R, Tian T, Wang Y, Enomoto T, Kimura T, et al:
Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid
adenocarcinoma and its clinical implications. Cancer Sci.
102:903–908. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Chang B, Liu G, Xue F, Rosen DG, Xiao L,
Wang X and Liu J: ALDH1 expression correlates with favorable
prognosis in ovarian cancers. Mod Pathol. 22:817–823.
2009.PubMed/NCBI
|
|
19.
|
Marcato P, Dean CA, Pan D, Araslanova R,
Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, et al:
Aldehyde dehydrogenase activity of breast cancer stem cells is
primarily due to isoform ALDH1A3 and its expression is predictive
of metastasis. Stem Cells. 29:32–45. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Gong C, Yao H, Liu Q, Chen J, Shi J, Su F
and Song E: Markers of tumor-initiating cells predict
chemoresistance in breast cancer. PLoS One. 5:e156302010.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Zhou S, Schuetz JD, Bunting KD, Colapietro
AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M,
Nakauchi H and Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is
expressed in a wide variety of stem cells and is a molecular
determinant of the side-population phenotype. Nat Med. 7:1028–1034.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Rasheed ZA, Yang J, Wang Q, Kowalski J,
Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X, et
al: Prognostic significance of tumorigenic cells with mesenchymal
features in pancreatic adenocarcinoma. J Natl Cancer Inst.
102:340–351. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu
Z, Stass SA and Jiang F: Aldehyde dehydrogenase 1 A1-positive cell
population is enriched in tumor-initiating cells and associated
with progression of bladder cancer. Cancer Epidemiol Biomarkers
Prev. 19:327–337. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z,
Stass SA and Jiang F: ALDH1A1 is a marker for malignant prostate
stem cells and predictor of prostate cancer patients' outcome. Lab
Invest. 90:234–244. 2010.PubMed/NCBI
|
|
25.
|
Dave B and Chang J: Treatment resistance
in stem cells and breast cancer. J Mammary Gland Biol Neoplasia.
14:79–82. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Lohberger B, Rinner B, Stuendl N, Absenger
M, Liegl-Atzwanger B, Walzer SM, Windhager R and Leithner A:
Aldehyde dehydrogenase 1, a potential marker for cancer stem cells
in human sarcoma. PLoS One. 7:e436642012. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Mo W and Zhang JT: Human ABCG2: structure,
function, and its role in multidrug resistance. Int J Biochem Mol
Biol. 3:1–27. 2012.PubMed/NCBI
|
|
28.
|
Ding XW, Wu JH and Jiang CP: ABCG2: a
potential marker of stem cells and novel target in stem cell and
cancer therapy. Life Sci. 86:631–637. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
An Y and Ongkeko WM: ABCG2: the key to
chemoresistance in cancer stem cells? Expert Opin Drug Metab
Toxicol. 5:1529–1542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
